[Chyuan Yu Biotech - KY] April 2026 Revenue 362 Million NTD (Year-on-Year +55.0%)

Key facts

  • [Chyuan Yu Biotech - KY] April 2026 Revenue 362 Million NTD (Year-on-Year +55.0%)
  • Chyuan Yu Biotech - KY announced April 2026 revenue of 362.005 million NTD, a significant increase of 55.0% year-on-year. This performance in the biotech and medical industry indicates strong growth.
  • Source: PR Times
  • Date: April 1, 2026

Direct answer

Chyuan Yu Biotech - KY announced April 2026 revenue of 362.005 million NTD, a significant increase of 55.0% year-on-year. This performance in the biotech and medical industry indicates strong growth.

Citation
[Chyuan Yu Biotech - KY] April 2026 Revenue 362 Million NTD (Year-on-Year +55.0%) (April 1, 2026), PR Times
Source
PR Times
Date
April 1, 2026
Chyuan Yu Biotech - KY announced April 2026 revenue of 362.005 million NTD, a significant increase of 55.0% year-on-year. This performance in the biotech and medical industry indicates strong growth.
その他NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 1, 2026 at 09:00
  • 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
  • 🤖 AI Analyzed: May 12, 2026 at 12:43 (4h 43m after Collected)
Company Code: 4148
Company Name: Chyuan Yu Biotech - KY
Industry: Biotechnology and Medical Industry
Data Month: 2026-04
Monthly Revenue: 362,005 thousand NTD (362 million)
Year-on-year change: +55.0%

Keywords: Monthly Revenue, Biotechnology and Medical Industry

FAQ

What are the key facts in this article?

Chyuan Yu Biotech - KY announced April 2026 revenue of 362.005 million NTD, a significant increase of 55.0% year-on-year. This performance in the biotech and medical industry indicates strong growth.

What is the direct answer?

Chyuan Yu Biotech - KY announced April 2026 revenue of 362.005 million NTD, a significant increase of 55.0% year-on-year. This performance in the biotech and medical industry indicates strong growth.

What is the source and date?

PR Times: https://openapi.twse.com.tw/revenue/twse-rev-4148-11504 | April 1, 2026